Asana Inc
For the period ended Oct 31, 2024. Filed Dec 5, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Oct 31, 2024 · Filed Dec 5, 2024
ASAN$9.59-4.3%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements Stockholders’ Equity
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY
| Three Months Ended October 31, 2024 | ||||||
|---|---|---|---|---|---|---|
| Common Stock · AdditionalPaid-In Capital · AccumulatedOther Comprehensive Loss · Accumulated Deficit · TotalStockholders’ Equity | ||||||
| Shares · Amount | ||||||
| Balances at July 31, 2024 | 229,489 | $2 | $1,942,911 | $(778) | $(1,650,218) | $291,917 |
| Issuance of common stock upon the exercise of options | 739 | — | 1,755 | — | — | 1,755 |
| Repurchases and retirement of common stock | (4,494) | — | — | — | (54,969) | (54,969) |
| Issuance of common stock upon the vesting and settlement of restricted stock units | 2,372 | — | (1) | — | — | (1) |
| Issuance of common stock under employee share purchase plan | 465 | — | 4,799 | — | — | 4,799 |
| Stock-based compensation expense | — | — | 53,300 | — | — | 53,300 |
| Net unrealized gains on marketable securities | — | — | — | 33 | — | 33 |
| Foreign currency translation adjustments | — | — | — | (238) | — | (238) |
| Net loss | — | — | — | — | (57,326) | (57,326) |
| Balances at October 31, 2024 | 228,571 | $2 | $2,002,764 | $(983) | $(1,762,513) | $239,270 |
| Three Months Ended October 31, 2023 | ||||||
|---|---|---|---|---|---|---|
| Common Stock · AdditionalPaid-In Capital · AccumulatedOther Comprehensive Loss · Accumulated Deficit · TotalStockholders’ Equity | ||||||
| Shares · Amount | ||||||
| Balances at July 31, 2023 | 219,606 | $2 | $1,706,006 | $(1,317) | $(1,370,438) | $334,253 |
| Issuance of common stock upon the exercise of options | 278 | — | 783 | — | — | 783 |
| Vesting of early exercised stock options | — | — | 2 | — | — | 2 |
| Issuance of common stock upon the vesting and settlement of restricted stock units | 2,100 | — | — | — | — | — |
| Issuance of common stock under employee share purchase plan | 420 | — | 6,511 | — | — | 6,511 |
| Stock-based compensation expense | — | — | 54,331 | — | — | 54,331 |
| Net unrealized losses on marketable securities | — | — | — | (236) | — | (236) |
| Foreign currency translation adjustments | — | — | — | (1,725) | — | (1,725) |
| Net loss | — | — | — | — | (61,750) | (61,750) |
| Balances at October 31, 2023 | 222,404 | $2 | $1,767,633 | $(3,278) | $(1,432,188) | $332,169 |
| Nine Months Ended October 31, 2024 | ||||||
|---|---|---|---|---|---|---|
| Common Stock · AdditionalPaid-In Capital · AccumulatedOther Comprehensive Loss · Accumulated Deficit · TotalStockholders’ Equity | ||||||
| Shares · Amount | ||||||
| Balances at January 31, 2024 | 224,728 | $2 | $1,821,216 | $(236) | $(1,494,586) | $326,396 |
| Issuance of common stock upon the exercise of options | 1,412 | — | 3,884 | — | — | 3,884 |
| Repurchases and retirement of common stock | (5,940) | — | — | — | (74,690) | (74,690) |
| Issuance of common stock upon the vesting and settlement of restricted stock units | 7,252 | — | (5) | — | — | (5) |
| Issuance of common stock under employee share purchase plan | 1,119 | — | 13,665 | — | — | 13,665 |
| Stock-based compensation expense | — | — | 164,004 | — | — | 164,004 |
| Net unrealized gains on marketable securities | — | — | — | 71 | — | 71 |
| Foreign currency translation adjustments | — | — | — | (818) | — | (818) |
| Net loss | — | — | — | — | (193,237) | (193,237) |
| Balances at October 31, 2024 | 228,571 | $2 | $2,002,764 | $(983) | $(1,762,513) | $239,270 |
| Nine Months Ended October 31, 2023 | ||||||
|---|---|---|---|---|---|---|
| Common Stock · AdditionalPaid-In Capital · AccumulatedOther Comprehensive Loss · Accumulated Deficit · TotalStockholders’ Equity | ||||||
| Shares · Amount | ||||||
| Balances at January 31, 2023 | 214,293 | $2 | $1,595,001 | $(873) | $(1,237,556) | $356,574 |
| Issuance of common stock upon the exercise of options | 1,649 | — | 3,856 | — | — | 3,856 |
| Vesting of early exercised stock options | — | — | 108 | — | — | 108 |
| Issuance of common stock upon the vesting and settlement of restricted stock units | 5,584 | — | (7) | — | — | (7) |
| Issuance of common stock under employee share purchase plan | 878 | — | 15,069 | — | — | 15,069 |
| Stock-based compensation expense | — | — | 153,606 | — | — | 153,606 |
| Net unrealized losses on marketable securities | — | — | — | (1,251) | — | (1,251) |
| Foreign currency translation adjustments | — | — | — | (1,154) | — | (1,154) |
| Net loss | — | — | — | — | (194,632) | (194,632) |
| Balances at October 31, 2023 | 222,404 | $2 | $1,767,633 | $(3,278) | $(1,432,188) | $332,169 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.